Sex-Specific Fifteen-Year Alcohol Consumption Trajectories and Their Association with Cardiovascular Events and Mortality: The Framingham Heart Study

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Alcohol use patterns influence health outcomes. This study examined sex-specific drinking trajectories and their associations with all-cause mortality and coronary heart disease (CHD) in the US-based Framingham Heart Study. Method: Among 6,570 participants (mean age: 55±13; 55% women) followed for 15 years, a growth mixture model identified four sex-specific alcohol consumption trajectories. Cox models examined associations of alcohol trajectories with CHD and mortality over 10 years of follow-up, adjusting for covariates. Results: The Moderate-Decreasing group (1,179 women, 0–14 g/day; 1,534 men, 0–28 g/day) showed a declining moderate intake. The Low-to-None group included light or non-drinkers (992 women, 826 men). The Inverse-U group (606 women, 199 men) showed variable intake, while the High-Decreasing group (858 women, 376 men) had high (women >14 and men >28 g/day) but declining consumption. Compared with Moderate-Decreasing, women in other groups had higher CHD risks (HRs 1.58-1.61) and greater mortality in Low-to-None (HR 1.25) and Inverse-U (HR 1.28) groups. Men in Low-to-None had higher mortality (HR 1.17) and CHD (HR 1.60), while High-Decreasing showed the highest mortality (HR 1.27). Low-to-moderate drinking was associated with lower mortality and CHD risks; however, these findings do not confirm the protective effects of alcohol use. Discussion: Our findings suggest that sustained low to moderate drinking was associated with lower risks of mortality and CHD in both women and men, compared to high-level or fluctuating patterns. These results emphasize the importance of understanding long-term drinking patterns in public health, but we caution against interpreting moderate use as a means to lower mortality risk or prevent CHD.

Article activity feed